Eyal Attar

Nessuna posizione attualmente

55 anni

Health Technology

Consumer Services

Profilo

Eyal C.
Attar formerly worked at Agios Pharmaceuticals, Inc., as Senior Medical Director from 2016 to 2019, Harvard Medical School, as Member-Leukemia Center, Aprea Therapeutics, Inc., as Chief Medical Officer & Senior Vice President, and Vor Biopharma, Inc., as Chief Medical Officer from 2022 to 2025.
Dr. Attar received his doctorate degree from UNC School of Medicine.

Precedenti posizioni note di Eyal Attar

Società	Posizione	Fine
VOR BIOPHARMA INC.	Direttore Tecnico/Scientifico/R&S	18/04/2025
AGIOS PHARMACEUTICALS, INC.	Direttore Tecnico/Scientifico/R&S	01/01/2019
Harvard Medical School Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
APREA THERAPEUTICS, INC.	Direttore Tecnico/Scientifico/R&S	-

Vedi nel dettaglio l'esperienza di Eyal Attar

Formazione di Eyal Attar

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Eyal Attar

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	5
Agios Pharmaceuticals, Inc. Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics	Health Technology
Harvard Medical School Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
UNC School of Medicine UNC School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Vor Biopharma, Inc. Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies	Health Technology
Aprea Therapeutics, Inc. Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds	Health Technology